New Year Bumper Sale @ Rs. 1 X
Amikatil 250 Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Urinary Tract Infection. Amikatil 250 Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Amikatil 250 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Amikatil 250 Injection side effects, there are can be others also. These have been listed below. Such side effects of Amikatil 250 Injection normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Amikatil 250 Injection has a Severe effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Amikatil 250 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Amikatil 250 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Amikatil 250 Injection in conditions like Dehydration, Parkinson's Disease, Hearing Loss. Other contraindications of Amikatil 250 Injection have been discussed in the sections ahead.
Besides this, Amikatil 250 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Amikatil 250 Injection is safe while driving, and is is addictive in nature.
Amikatil 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Amikatil 250 Injection safe for pregnant women?
Amikatil has many dangerous side effects in pregnant women. If you are pregnant, do not consume Amikatil without medical advice.
Is the use of Amikatil 250 Injection safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Amikatil for breastfeeding women are not known.
What is the effect of Amikatil 250 Injection on the Kidneys?
Use of Amikatil may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Amikatil 250 Injection on the Liver?
Side effects of Amikatil rarely affect the liver.
What is the effect of Amikatil 250 Injection on the Heart?
Side effects of Amikatil rarely affect the heart.
Amikatil 250 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Amikatil 250 Injection unless your doctor advises you to do so -
Is this Amikatil 250 Injection habit forming or addictive?
No, there is no any evidence that Amikatil 250 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Amikatil 250 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Amikatil 250 Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Amikatil 250 Injection cannot treat any kind of mental disorder.
Interaction between Food and Amikatil 250 Injection
Taking Amikatil 250 Injection with food does not harm your health.
Interaction between Alcohol and Amikatil 250 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Amikatil 250 Injection.
Yes, Amikatil is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Amikatil taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Amikatil with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
Yes, Amikatil is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
Occasionally, Amikatil can cause drug-induced thrombocytopenia (blood clot formation in the vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Yes, Amikatil has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
Yes, Amikatil is effective against bacteria (Pseudomonas). But it is also found that Pseudomonas can get resistant to this drug and in that case Amikatil will not produce desired results. If you are experiencing no symptomatic relief after taking this medicine then inform your doctor and follow his/her instructions.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137